𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase

✍ Scribed by Peter G. Steinherz


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
731 KB
Volume
74
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Combination therapy with methotrexate, v
✍ Alvaro Aguayo; Jorge Cortes; Deborah Thomas; Sherry Pierce; Michael Keating; Hag πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 2 views

BACKGROUND. L-asparaginase in combination with methotrexate has synergistic antileukemic activity in a schedule-dependent fashion. A new preparation of L-asparaginase, polyethylene-glycol conjugated (PEG)-asparaginase, is a pharmacologically different formulation of L-asparaginase with distinct prop

Remission induction with L-asparaginase,
✍ Land, Vita J. ;Sutow, Wataru W. ;Dyment, Paul G. ;Falletta, John M. ;Morgan, Sam πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 522 KB

## Abstract Forty‐five children with acute nonlymphoblastic leukemia in relapse received a total of 56 courses of L‐asparaginase combined with vincristine and prednisone. The complete remission rate of 40% (12 of 30 trials) in patients resistant to vincristine and prednisone was almost identical to

Osteonecrosis in pediatric patients with
✍ Ronald G. Murphy; Mark L. Greenberg πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 403 KB πŸ‘ 2 views

The authors report five pediatric patients with acute lymphoblastic leukemia (ALL) in whom symptomatic aseptic osteonecrosis developed on therapy. All patients had been on treatment with a modified BFM protocol and developed osteonecrosis in the maintenance phase of the protocol. The avascular necro

Severe life-threatening hyperphosphatemi
✍ Milionis, Haralampos J.; Elisaf, Moses S. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 337 KB πŸ‘ 2 views

FL 33612 to permit rapid consideration for publication. ## Recurrent Lymphocytic Pleural Effusion After Intravenous Immunoglobulin To the Editor: A 35-year-old female was initially diagnosed in 1981 with stage IIA Hodgkin's disease treated successfully with MOPP (mechlorethamine, oncovin, procarb